Member Article

AI firm becomes first in Europe to utilise world-leading deep learning supercomputer

UK artificial intelligence (AI) company, BenevolentAI, is to become the first business in Europe to utilise a purpose-built version of the world’s most advanced AI supercomputer.

The DGX-1 has been developed by hardware manufacturer NVIDIA and is built around the firm’s Tesla technology which has been designed specifically for AI and data research purposes.

Kings Cross-based BenevolentAI utilise machine learning and AI to monitor, collate and combine vast amounts of scientific and medical information to come up with new drug therapies and potential advances for some the biggest biomedical problems in science.

By utilising machine learning, and combining researchers with computing, the BenevolentAI says it can test hypotheses and draw conclusions significantly quicker than any team of human researchers could manage.

Its proprietary Judgement Augmented Cognition System (JACS) utilises language processing, AI and deep learning to make sense of and draw connections between vast amounts of scientific data.

Ken Mulvany, Co-founder and Director of BenevolentAI, commented: “There are 10,000 updates per day on PubMed alone, presenting an impossible challenge to scientists to keep up with the rate at which new scientific knowledge is produced.

“This new AI supercomputer will boost our processing power and accelerate the creation of new relationships amongst disparate information sources to yield faster scientific innovation.

“For the current application of our AI technology in the bioscience space, it will mean that new drug discoveries can be made faster and more efficiently than ever before.”